vs
Side-by-side financial comparison of JFrog Ltd (FROG) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
JFrog Ltd is the larger business by last-quarter revenue ($145.3M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 25.2%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 20.4%).
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FROG vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $145.3M | $75.5M |
| Net Profit | $-15.2M | — |
| Gross Margin | 77.9% | 69.3% |
| Operating Margin | -14.7% | 22.7% |
| Net Margin | -10.5% | — |
| Revenue YoY | 25.2% | 27.7% |
| Net Profit YoY | 34.4% | — |
| EPS (diluted) | $-0.13 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $145.3M | $75.5M | ||
| Q3 25 | $136.9M | $54.5M | ||
| Q2 25 | $127.2M | $52.4M | ||
| Q1 25 | $122.4M | $46.0M | ||
| Q4 24 | $116.1M | $59.1M | ||
| Q3 24 | $109.1M | $80.5M | ||
| Q2 24 | $103.0M | $47.1M | ||
| Q1 24 | $100.3M | $43.8M |
| Q4 25 | $-15.2M | — | ||
| Q3 25 | $-16.4M | $8.8M | ||
| Q2 25 | $-21.7M | $5.9M | ||
| Q1 25 | $-18.5M | $3.0M | ||
| Q4 24 | $-23.2M | — | ||
| Q3 24 | $-22.9M | $20.3M | ||
| Q2 24 | $-14.3M | $-4.5M | ||
| Q1 24 | $-8.8M | $-4.8M |
| Q4 25 | 77.9% | 69.3% | ||
| Q3 25 | 77.4% | 77.7% | ||
| Q2 25 | 76.3% | 76.5% | ||
| Q1 25 | 75.3% | 77.1% | ||
| Q4 24 | 75.4% | 76.4% | ||
| Q3 24 | 75.0% | 63.9% | ||
| Q2 24 | 78.8% | 77.4% | ||
| Q1 24 | 79.5% | 75.5% |
| Q4 25 | -14.7% | 22.7% | ||
| Q3 25 | -15.8% | 17.6% | ||
| Q2 25 | -20.4% | 12.7% | ||
| Q1 25 | -18.8% | 8.7% | ||
| Q4 24 | -21.9% | 22.6% | ||
| Q3 24 | -27.4% | 27.4% | ||
| Q2 24 | -18.6% | -4.6% | ||
| Q1 24 | -16.6% | -5.3% |
| Q4 25 | -10.5% | — | ||
| Q3 25 | -12.0% | 16.2% | ||
| Q2 25 | -17.0% | 11.2% | ||
| Q1 25 | -15.1% | 6.5% | ||
| Q4 24 | -20.0% | — | ||
| Q3 24 | -21.0% | 25.2% | ||
| Q2 24 | -13.9% | -9.6% | ||
| Q1 24 | -8.8% | -11.0% |
| Q4 25 | $-0.13 | $0.26 | ||
| Q3 25 | $-0.14 | $0.17 | ||
| Q2 25 | $-0.19 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $-0.21 | $0.40 | ||
| Q3 24 | $-0.21 | $0.41 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $704.4M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $887.4M | $130.3M |
| Total Assets | $1.3B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $704.4M | $97.5M | ||
| Q3 25 | $651.1M | $94.4M | ||
| Q2 25 | $611.7M | $96.0M | ||
| Q1 25 | $563.5M | $93.2M | ||
| Q4 24 | $522.0M | $101.0M | ||
| Q3 24 | $467.8M | $96.7M | ||
| Q2 24 | $591.3M | $96.8M | ||
| Q1 24 | $579.6M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $887.4M | $130.3M | ||
| Q3 25 | $859.4M | $115.3M | ||
| Q2 25 | $826.5M | $104.7M | ||
| Q1 25 | $800.0M | $97.1M | ||
| Q4 24 | $773.5M | $92.1M | ||
| Q3 24 | $756.2M | $71.1M | ||
| Q2 24 | $721.4M | $48.5M | ||
| Q1 24 | $707.8M | $51.0M |
| Q4 25 | $1.3B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.0B | $205.0M | ||
| Q1 24 | $997.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.7M | $14.4M |
| Free Cash FlowOCF − Capex | $49.9M | $14.4M |
| FCF MarginFCF / Revenue | 34.3% | 19.1% |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $142.3M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.7M | $14.4M | ||
| Q3 25 | $30.2M | $9.7M | ||
| Q2 25 | $36.1M | $14.1M | ||
| Q1 25 | $28.8M | $3.6M | ||
| Q4 24 | $49.1M | $15.6M | ||
| Q3 24 | $27.6M | $11.0M | ||
| Q2 24 | $16.7M | $1.0M | ||
| Q1 24 | $17.5M | $11.2M |
| Q4 25 | $49.9M | $14.4M | ||
| Q3 25 | $28.8M | $9.7M | ||
| Q2 25 | $35.5M | $14.1M | ||
| Q1 25 | $28.1M | $3.6M | ||
| Q4 24 | $48.5M | $15.6M | ||
| Q3 24 | $26.7M | $11.0M | ||
| Q2 24 | $16.0M | $1.0M | ||
| Q1 24 | $16.6M | — |
| Q4 25 | 34.3% | 19.1% | ||
| Q3 25 | 21.0% | 17.7% | ||
| Q2 25 | 27.9% | 26.8% | ||
| Q1 25 | 23.0% | 7.7% | ||
| Q4 24 | 41.8% | 26.4% | ||
| Q3 24 | 24.5% | 13.7% | ||
| Q2 24 | 15.5% | 2.1% | ||
| Q1 24 | 16.6% | — |
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 1.0% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
